10.12.2012 Views

netLibrary - eBook Summary Structure-based Drug Design by ...

netLibrary - eBook Summary Structure-based Drug Design by ...

netLibrary - eBook Summary Structure-based Drug Design by ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Document<br />

IX. Conclusions<br />

Page 289<br />

Factor Xa is clearly an important component of the coagulation process and inhibition of this enzyme<br />

can lead to potent anticoagulant effects. Recently, a number of naturally occurring anti-Factor-Xa<br />

polypeptides have been isolated from several hematophagous organisms including ticks, leeches, and<br />

hook- worms. With the exception of TAP, these molecules appear to bind to Factor Xa <strong>by</strong> the standard<br />

mechanism of inhibition proposed earlier [49]. The sequence information derived from these inhibitors<br />

as well as the natural cleavage sites of substrates of Factor Xa can be used along with the conformational<br />

constraints imposed <strong>by</strong> the proposed substrate-like binding to define the pharmacophore requirements of<br />

the active site of Factor Xa. The structurally rigid BPTI mutants, which have been found to be potent<br />

Factor Xa inhibitors, also provide important conformational information particularly with regard to the<br />

specific binding interactions on the P' side of the Factor Xa active site. A number of small molecule<br />

inhibitors have also recently been reported which appear to take advantage of a unique cation-π S4-site<br />

available in Factor Xa to achieve good selectivity with moderate potency. The availbility of the X-ray<br />

structure of native Factor Xa has allowed molecular modeling approaches to suggest possible fits of<br />

these inhibitors to the Factor Xa active site.<br />

Note Added in Proof<br />

After this review was written, the x-ray structure of Factor Xa with DX-9065a was reported [81].<br />

References<br />

1. Proteinase inhibitors. In: Barrett AJ, Salvesen G, eds. Research Monographs in Cell and Tissue<br />

Physiology. Vol 12. New York: Elsevier, 1986. <strong>Design</strong> of Enzyme Inhibitors as <strong>Drug</strong>s. Sandler M,<br />

Smith HJ, eds. New York: Oxford University Press, 1989.<br />

2. Colman RW, Hirsh J, Marder VJ, Salzman EW. Hemostasis and Thrombosis. Basic Principles and<br />

Clinical Practice. Second Edition. Philadelphia: J. B. Lippincott Company, 1987.<br />

3. Hathaway, WE, Goodnight, Jr SH. Disorders of Hemostasis and Thrombosis. New York: McGraw-<br />

Hill, 1993.<br />

4. Padmanabhan K, Padmanabhan KP, Tulinsky A, Park CH, Bode W, Huber R, Blankenship DT,<br />

Cardin AD, Kisiel W. <strong>Structure</strong> of human Des(1–45) factor Xa at 2.2 Å resolution. J Mol Biol 1993;<br />

232:947–966.<br />

http://legacy.netlibrary.com/nlreader/nlReader.dll?bookid=12640&filename=Page_289.html [4/5/2004 5:15:45 PM]

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!